4D Molecular Therapeutics (NASDAQ:FDMT) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPS
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) released its earnings results on Tuesday. The company reported ($0.66) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.07, Zacks reports. The firm had revenue of $0.03 million during the quarter, compared to analyst estimates of $1.44 million. 4D Molecular Therapeutics had […]
More Stories
NVIDIA Co. (NASDAQ:NVDA) Shares Sold by Swiss National Bank
Swiss National Bank lessened its stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 5.1% during the fourth...
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Sells 54,460 Shares of NVIDIA Co. (NASDAQ:NVDA)
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD cut its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free...
NVIDIA Co. (NASDAQ:NVDA) Holdings Increased by Avantax Advisory Services Inc.
Avantax Advisory Services Inc. lifted its holdings in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 2.6% in the 4th quarter,...
Hudock Inc. Sells 602 Shares of Apple Inc. (NASDAQ:AAPL)
Hudock Inc. lowered its position in Apple Inc. (NASDAQ:AAPL – Free Report) by 1.7% in the 4th quarter, according to...
Synovus Financial Corp. (NYSE:SNV) Stake Cut by Legal & General Group Plc
Legal & General Group Plc lowered its holdings in Synovus Financial Corp. (NYSE:SNV – Free Report) by 8.9% during the...
Fyre Festival 2 Postponed: Organizers Issue Refunds Amid Permit Issues
Fyre Festival 2, the much-anticipated sequel to the infamous 2017 event, has been officially postponed. Originally scheduled for May 30...